AstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...

As global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...

Pharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while talent shorta...

Offshore betting promotions are proliferating across India, despite the government's crackdown on online gambling and its related advertise...

India’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...

The United States is accelerating research into psychedelic drugs for mental illness. This shift prompts India to re-evaluate its own drug ...

India's pharmaceutical landscape is on the verge of transformation! The country’s drug regulatory body is gearing up for an overhaul with t...

As global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.

The Central Drugs Standard Control Organisation has moved about 95 officials across India. This reshuffle aims to improve compliance and le...

The proposed platform will enable real-time, end-to-end digital tracking of all regulated pharmaceutical products, covering every stage fro...

India's drug regulator has directed state authorities to enforce strict testing of all raw materials used in medicines. This action follows...

Despite concerns about cancer-causing agents in Ranitidine and an expert panel's recommendation to suspend it, India's drug advisory body h...

The drug regulatory body also advised doctors and healthcare professionals to carefully prescribe and educate their patients to discontinue...

On November 11, last year, Dr VG Somani's term as DCGI was extended for three months, for the second time, coming into effect on November 1...

His comments came on Sunday in the backdrop of questions being raised about the quality of Indian drugs over the past few months. The lates...

The OPPI, which represents 22 pharma companies, including Abbott, Pfizer, Novartis, Novo Nordisk and Sanofi, also wants specialised patent ...

A panel will look into the findings of the 59th Report of the Parliamentary Standing Committee on the functioning of the Central Drugs Stan...